A Clinician's Perspective: Commentaries from the Journal of the American Academy of Dermatology

In a recent talk, Warren Heyman, an experienced dermatologist, shared insights from his ongoing column in the Journal of the American Academy of Dermatology, titled "A Clinician's Perspective," which began in 2018. He emphasized the need for dermatologists to extract practical, applicable knowledge from extensive medical literature. Heyman discussed various clinical considerations, including the use of hydroxychloroquine for lupus and dermatomyositis and the importance of monitoring latent tuberculosis and cardio toxicity associated with it. He underscored the evolving understanding of conditions such as Henoch-Schönlein purpura in adults, the relevance of early recognition of acute inflammatory edema, and the implications of increasing usage of spironolactone for conditions like acne. The discussion extended to autoimmune responses linked to medications such as vancomycin, connections between COVID-19 and skin manifestations, and the need for vigilance regarding potential lymphoproliferative disorders associated with dupilumab use. The talk also highlighted a declining trend of melanoma incidences in younger populations and the emotional impacts patients face upon a melanoma diagnosis. Heyman encouraged dermatologists to stay informed through rigorous evaluation of medical literature and to introspect on how to implement new findings into practice effectively.